Reducing greenhouse gas emissions is a major challenge. Inhalers have a significant impact on the environment due to their greenhouse gas emissions. However, inhalation therapy plays a fundamental and essential role in the treatment of patients with cystic fibrosis. They therefore represent a target group with high potential for the implementation of strategic measures to reduce the environmental impact of devices.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
Opicapon: double benefit for motor function and sleep in Parkinson’s disease
- Colorectal cancer
Is exercise better than medication?
- Itching in primary biliary cholangitis
When the skin becomes agony
- TREATswitzerland Register
Evaluation of system therapies for AD
- Cardiogenic shock - 2025 update
Between standardization, team processes and targeted cycle support
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Multiple sclerosis
Avoiding the nocebo trap with natalizumab biosimilars
- COPD and comorbidities